Published in Eur J Pharmacol on August 08, 2003
Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin. Brain Res (2009) 1.11
Nociceptin Opioid Receptor (NOP) as a Therapeutic Target: Progress in Translation from Preclinical Research to Clinical Utility. J Med Chem (2016) 1.10
Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists. J Pharmacol Exp Ther (2009) 1.04
Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems. Pharmacol Rev (2016) 1.02
Comparison of the antinociceptive and antirewarding profiles of novel bifunctional nociceptin receptor/mu-opioid receptor ligands: implications for therapeutic applications. J Pharmacol Exp Ther (2009) 1.01
The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence. Pharmacol Ther (2013) 0.98
A neuropeptide-centric view of psychostimulant addiction. Br J Pharmacol (2008) 0.97
The endogenous OFQ/N/ORL-1 receptor system regulates the rewarding effects of acute cocaine. Neuropharmacology (2007) 0.90
The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications. Curr Top Med Chem (2011) 0.89
Retrodialysis of N/OFQ into the nucleus accumbens shell blocks cocaine-induced increases in extracellular dopamine and locomotor activity. Eur J Pharmacol (2012) 0.81
BU08073 a buprenorphine analogue with partial agonist activity at μ-receptors in vitro but long-lasting opioid antagonist activity in vivo in mice. Br J Pharmacol (2014) 0.80
A key role for the N/OFQ-NOP receptor system in modulating nicotine taking in a model of nicotine and alcohol co-administration. Sci Rep (2016) 0.79
Nociceptin induces hypophagia in the perifornical and lateral hypothalamic area. PLoS One (2012) 0.79
Differential pharmacological actions of methadone and buprenorphine in human embryonic kidney 293 cells coexpressing human μ-opioid and opioid receptor-like 1 receptors. Neurochem Res (2011) 0.78
Knock-In Mice with NOP-eGFP Receptors Identify Receptor Cellular and Regional Localization. J Neurosci (2015) 0.78
Nociceptin receptor activation does not alter acquisition, expression, extinction and reinstatement of conditioned cocaine preference in mice. Brain Res (2015) 0.77
Identification of neuropeptide receptors expressed by melanin-concentrating hormone neurons. J Comp Neurol (2014) 0.77
Regulation of opioid gene expression in the rat brainstem by 3,4-methylenedioxymethamphetamine (MDMA): role of serotonin and involvement of CREB and ERK cascade. Naunyn Schmiedebergs Arch Pharmacol (2010) 0.76
Buprenorphine-elicited alteration of adenylate cyclase activity in human embryonic kidney 293 cells coexpressing κ-, μ-opioid and nociceptin receptors. J Cell Mol Med (2015) 0.75
Participation of the nociceptin/orphanin FQ receptor in ethanol-mediated locomotor activation and ethanol intake in preweanling rats. Behav Brain Res (2013) 0.75
Recommendations from the 2008 International Summit on Proteomics Data Release and Sharing Policy: the Amsterdam principles. J Proteome Res (2009) 3.77
Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother (2004) 2.34
The proteomic analysis of primary cortical astrocyte cell culture after morphine administration. J Proteome Res (2009) 1.55
A practical guide to nano-LC troubleshooting. J Sep Sci (2007) 1.44
Methods for samples preparation in proteomic research. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 1.08
Implementation of proteomic biomarkers: making it work. Eur J Clin Invest (2012) 1.00
Acid-labile surfactant assists in-solution digestion of proteins resistant to enzymatic attack. Rapid Commun Mass Spectrom (2004) 0.95
Rat brain proteome in morphine dependence. Neurochem Int (2006) 0.92
The activity of CART peptide fragments. Peptides (2006) 0.92
N-terminal H3/D3-acetylation for improved high-throughput peptide sequencing by matrix-assisted laser desorption/ionization mass spectrometry with a time-of-flight/time-of-flight analyzer. Rapid Commun Mass Spectrom (2006) 0.91
Antifungal action of human cathelicidin fragment (LL13-37) on Candida albicans. Peptides (2011) 0.91
An enhanced method for peptides sequencing by N-terminal derivatization and MS. Proteomics (2005) 0.90
Effects of cathelicidin and its fragments on three key enzymes of HIV-1. Peptides (2011) 0.89
Proteomics in neurosciences. Mass Spectrom Rev (2007) 0.89
Catecholamines and methods for their identification and quantitation in biological tissues and fluids. J Neurosci Methods (2002) 0.88
The new face of nucleolin in human melanoma. Cancer Immunol Immunother (2009) 0.87
Effects of imperatorin on scopolamine-induced cognitive impairment and oxidative stress in mice. Psychopharmacology (Berl) (2014) 0.87
Non-peptidergic OP4 receptor agonist inhibits morphine antinociception but does not influence morphine dependence. Neuroreport (2003) 0.86
Activities of temporin family peptides against the chytrid fungus (Batrachochytrium dendrobatidis) associated with global amphibian declines. Antimicrob Agents Chemother (2003) 0.86
Examples of peptide-peptoid hybrid serine protease inhibitors based on the trypsin inhibitor SFTI-1 with complete protease resistance at the P1-P1' reactive site. Chembiochem (2005) 0.86
In vitro and in vivo analyses of the biological activity of RGD peptides towards Ab Bomirski melanoma. Cell Mol Biol Lett (2003) 0.86
The dimeric and tetrameric octarepeat fragments of prion protein behave differently to its monomeric unit. Dalton Trans (2004) 0.86
Sunflower trypsin inhibitor 1 as a molecular scaffold for drug discovery. Curr Pharm Des (2011) 0.85
Proteomic analysis of striatal neuronal cell cultures after morphine administration. J Sep Sci (2009) 0.85
The effects of imperatorin on anxiety and memory-related behavior in male Swiss mice. Exp Clin Psychopharmacol (2012) 0.85
Proteomic analysis of rat cerebral cortex, hippocampus and striatum after exposure to morphine. Int J Mol Med (2006) 0.84
A novel cryptic peptide derived from the rat neuropeptide FF precursor reverses antinociception and conditioned place preference induced by morphine. Peptides (2007) 0.83
Effects of imperatorin on nicotine-induced anxiety- and memory-related responses and oxidative stress in mice. Physiol Behav (2013) 0.83
Design of selective substrates of proteinase 3 using combinatorial chemistry methods. Anal Biochem (2008) 0.83
Respective roles of dopamine D2 and D3 receptors in food-seeking behaviour in rats. Psychopharmacology (Berl) (2003) 0.83
Introduction of alpha-hydroxymethyamino acid residues in substrate specificity P1 position of trypsin inhibitor SFTI-1 from sunflower seeds retains its activity. Biochem Biophys Res Commun (2005) 0.83
Design of serine proteinase inhibitors by combinatorial chemistry using trypsin inhibitor SFTI-1 as a starting structure. J Pept Sci (2007) 0.82
Proteomics and peptidomics in neuroscience. Experience of capabilities and limitations in a neurochemical laboratory. J Mass Spectrom (2005) 0.81
Implication of the disulfide bridge in trypsin inhibitor SFTI-1 in its interaction with serine proteinases. Bioorg Med Chem (2010) 0.81
Neuropeptide FF (NPFF) reduces the expression of morphine- but not of ethanol-induced conditioned place preference in rats. Peptides (2007) 0.81
Trypsin inhibitors from the garden four o'clock (Mirabilis jalapa) and spinach (Spinacia oleracea) seeds: isolation, characterization and chemical synthesis. Phytochemistry (2007) 0.81
Effects of calcium channel antagonists on the motivational effects of nicotine and morphine in conditioned place aversion paradigm. Behav Brain Res (2011) 0.80
The new fluorogenic substrates of neutrophil proteinase 3 optimized in prime site region. Anal Biochem (2010) 0.80
Characterisation of a highly specific, endogenous inhibitor of cysteine protease from Staphylococcus epidermidis, a new member of the staphostatin family. Biol Chem (2004) 0.80
Magnetic scavengers as carriers of analytes for flowing atmospheric pressure afterglow mass spectrometry (FAPA-MS). Analyst (2015) 0.79
Selenopeptide analogs of EETI-II retain potent trypsin inhibitory activities. Chem Biol Drug Des (2010) 0.79
The role of neuropeptide FF (NPFF) in the expression of sensitization to hyperlocomotor effect of morphine and ethanol. Neuropeptides (2006) 0.79
Direct analysis of methcathinone from crude reaction mixture by flowing atmospheric-pressure afterglow mass spectrometry. Rapid Commun Mass Spectrom (2012) 0.79
Proteome analysis of mouse primary astrocytes. Neurochem Int (2005) 0.79
Reversible lysine acetylation regulates activity of human glycine N-acyltransferase-like 2 (hGLYATL2): implications for production of glycine-conjugated signaling molecules. J Biol Chem (2012) 0.79
Morphinome--a meta-analysis applied to proteomics studies in morphine dependence. Proteomics (2010) 0.79
Molecular scavengers as carriers of analytes for mass spectrometry identification. Anal Chem (2014) 0.79
Cysteine protease inhibitors suppress the development of tolerance to morphine antinociception. Neuropeptides (2008) 0.78
Antibiotic properties of novel synthetic temporin A analogs and a cecropin A-temporin A hybrid peptide. Protein Pept Lett (2002) 0.78
Three wavelength substrate system of neutrophil serine proteinases. Anal Chem (2012) 0.78
Structural and dynamic characterization of copper(II) binding of the human prion protein outside the octarepeat region. Chemistry (2007) 0.78
Chemical synthesis and kinetic study of the smallest naturally occurring trypsin inhibitor SFTI-1 isolated from sunflower seeds and its analogues. Biochem Biophys Res Commun (2002) 0.78
Inhibitory and antimicrobial activities of OGTI and HV-BBI peptides, fragments and analogs derived from amphibian skin. Peptides (2012) 0.78
Cryptic peptide derived from the rat neuropeptide FF precursor affects G-proteins linked to opioid receptors in the rat brain. Peptides (2008) 0.78
Crypteins derived from the mouse neuropeptide FF (NPFF)A precursor display NPFF-like effects in nociceptive tests in mice. Peptides (2012) 0.78
Fluorescent analogs of trypsin inhibitor SFTI-1 isolated from sunflower seeds-synthesis and applications. Biopolymers (2014) 0.78
Substrate specificity of Staphylococcus aureus cysteine proteases--Staphopains A, B and C. Biochimie (2011) 0.78
Atomic resolution crystal structure of HV-BBI protease inhibitor from amphibian skin in complex with bovine trypsin. Proteins (2015) 0.78
Designing of substrates and inhibitors of bovine alpha-chymotrypsin with synthetic phenylalanine analogues in position P(1). Protein Pept Lett (2008) 0.77
New potent cathepsin G phosphonate inhibitors. Bioorg Med Chem (2008) 0.77
Development of sensitive cathepsin G fluorogenic substrate using combinatorial chemistry methods. Anal Biochem (2008) 0.77
Analogues of trypsin inhibitor SFTI-1 with disulfide bridge substituted by various length of carbonyl bridges. Protein Pept Lett (2010) 0.77
Determination of psychostimulants and their metabolites by electrochemistry linked on-line to flowing atmospheric pressure afterglow mass spectrometry. Analyst (2014) 0.77
Neuropeptide FF (NPFF) reduces the expression of cocaine-induced conditioned place preference and cocaine-induced sensitization in animals. Peptides (2008) 0.77
CART (85-102)-inhibition of psychostimulant-induced hyperlocomotion: importance of cyclization. Peptides (2006) 0.77
[Nociceptin/orphanin FQ (N/OFQ)--the opioid, antiopioid or neuromodulator?]. Postepy Hig Med Dosw (Online) (2004) 0.76
iTRAQ analysis with Paul ion trap-obstacle solved. J Proteome Res (2013) 0.76
Differential effects of N-peptidyl-O-acyl hydroxylamines on dynorphin-induced antinociception in the mouse capsaicin test. Neuropeptides (2005) 0.76
Inhibitory activity of double-sequence analogues of trypsin inhibitor SFTI-1 from sunflower seeds: an example of peptide splicing. FEBS J (2010) 0.76
Selection of new chromogenic substrates of serine proteinases using combinatorial chemistry methods. Comb Chem High Throughput Screen (2007) 0.76
Biochemical and structural characterization of SplD protease from Staphylococcus aureus. PLoS One (2013) 0.76
Synthesis and characterisation of PEG-peptide surfaces for proteolytic enzyme detection. Anal Bioanal Chem (2013) 0.76
Introduction of Pro and its analogues in the conserved P1' position of trypsin inhibitor SFTI-1 retains its inhibitory activity. Protein Pept Lett (2011) 0.76
A comparative study of glycoproteomes in androgen-sensitive and -independent prostate cancer cell lines. Mol Cell Biochem (2013) 0.76
Introduction of non-natural amino acid residues into the substrate-specific P1 position of trypsin inhibitor SFTI-1 yields potent chymotrypsin and cathepsin G inhibitors. Bioorg Med Chem (2009) 0.76
Effect of neramexane on ethanol dependence and reinforcement. Eur J Pharmacol (2004) 0.76
Expanding chemical diversity of conotoxins: peptoid-peptide chimeras of the sodium channel blocker μ-KIIIA and its selenopeptide analogues. Eur J Med Chem (2013) 0.75
Crypteins--an overlooked piece of peptide systems. Curr Protein Pept Sci (2015) 0.75
Constant activity of glutamine synthetase after morphine administration versus proteomic results. Anal Bioanal Chem (2010) 0.75
Identification of bikunin as an endogenous inhibitor of dynorphin convertase in human cerebrospinal fluid. FEBS J (2006) 0.75
Mephedrone and nicotine: oxidative stress and behavioral interactions in animal models. Neurochem Res (2015) 0.75
Differential binding of tropomyosin isoforms to actin modified with m-maleimidobenzoyl-N-hydroxysuccinimide ester and fluorescein-5-isothiocyanate. Anal Biochem (2009) 0.75
Dynorphin convertases and their functions in CNS. Curr Pharm Des (2013) 0.75
Synthesis of metabolites of paracetamol and cocaine via photooxidation on TiO2 catalyzed by UV light. J Photochem Photobiol B (2012) 0.75
Activities of Venom Proteins and Peptides with Possible Therapeutic Applications from Bees and WASPS. Protein Pept Lett (2016) 0.75
Suppressive effects by cysteine protease inhibitors on naloxone-precipitated withdrawal jumping in morphine-dependent mice. Neuropeptides (2010) 0.75
Myeloperoxidase-catalyzed oxidative inactivation of human kininogens: the impairment of kinin-precursor and prekallikrein-binding functions. Biol Chem (2011) 0.75